Increased platelet depleted plasma 5-hydroxytryptamine concentration following meal ingestion in symptomatic female subjects with diarrhoea predominant irritable bowel syndrome
about
Enteroendocrine cells: neglected players in gastrointestinal disorders?Physiological underpinnings of irritable bowel syndrome: neurohormonal mechanismsRole of central vagal 5-HT3 receptors in gastrointestinal physiology and pathophysiologyIntestinal secretory mechanisms in irritable bowel syndrome-diarrheaGenetic polymorphism in pathogenesis of irritable bowel syndromeThe vagus nerve in appetite regulation, mood and intestinal inflammationAn Endogenous Tachykinergic NK2/NK3 Receptor Cascade System Controlling the Release of Serotonin from Colonic MucosaTianeptine vs amitriptyline for the treatment of irritable bowel syndrome with diarrhea: a multicenter, open-label, non-inferiority, randomized controlled studyMechanisms mediating serotonin-induced contraction of colonic myocytes.New pathophysiological mechanisms in irritable bowel syndrome.Pharmacologic and complementary and alternative medicine therapies for irritable bowel syndrome.Serotonin signalling in the gut--functions, dysfunctions and therapeutic targets.Gender-related differences in irritable bowel syndrome: potential mechanisms of sex hormones.Irritable bowel syndrome: pathogenesis, diagnosis, treatment, and evidence-based medicineRNA sequencing shows transcriptomic changes in rectosigmoid mucosa in patients with irritable bowel syndrome-diarrhea: a pilot case-control study.Identification of a functional TPH1 polymorphism associated with irritable bowel syndrome bowel habit subtypes.Plasma 5-hydroxytryptamine concentration and its correlation with psychopathology in patients with irritable bowel syndrome.Association Between SLC6A4 Serotonin Transporter Gene Lainked Polymorphic Region and ADRA2A -1291C>G and Irritable Bowel Syndrome in KoreaRecent advances in pharmacological treatment of irritable bowel syndrome.Acute tryptophan depletion affects brain-gut responses in irritable bowel syndrome patients and controls.Treating irritable bowel syndrome with a food elimination diet followed by food challenge and probiotics.Guidelines on the irritable bowel syndrome: mechanisms and practical management.Associations of tryptophan hydroxylase gene polymorphisms with irritable bowel syndrome.LX-1031, a tryptophan 5-hydroxylase inhibitor, and its potential in chronic diarrhea associated with increased serotoninThe relationship between perioperative nausea and vomiting and serum serotonin concentrations in patients undergoing cesarean section under epidural anesthesia.Association study of serotonin transporter SLC6A4 gene with Chinese Han irritable bowel syndrome.Subjective food hypersensitivity: assessment of enterochromaffin cell markers in blood and gut lavage fluid.Modulation of human serotonin transporter expression by 5-HTTLPR in colon cells.Characteristics of 5-hydroxytryptamine receptors involved in contraction of feline ileal longitudinal smooth muscle.Of actors, bolting horses, and drops in oceans!Association between a functional polymorphism in the serotonin transporter gene and diarrhoea predominant irritable bowel syndrome in women.Schisandra chinensis reverses visceral hypersensitivity in a neonatal-maternal separated rat model.Do fluctuations in ovarian hormones affect gastrointestinal symptoms in women with irritable bowel syndrome?JCM-16021, a Chinese Herbal Formula, Attenuated Visceral Hyperalgesia in TNBS-Induced Postinflammatory Irritable Bowel Syndrome through Reducing Colonic EC Cell Hyperplasia and Serotonin Availability in RatsPlasticity of gastrointestinal vagal afferent satiety signals.Glucose-dependent trafficking of 5-HT3 receptors in rat gastrointestinal vagal afferent neurons.The rationale, efficacy and safety evidence for tegaserod in the treatment of irritable bowel syndrome.A role for endogenous peptide YY in tachykinin NK(2) receptor-triggered 5-HT release from guinea pig isolated colonic mucosaBrief report: normal intestinal permeability at elevated platelet serotonin levels in a subgroup of children with pervasive developmental disorders in Curaçao (The Netherlands antilles).Drugs acting on serotonin receptors for the treatment of functional GI disorders.
P2860
Q24629026-1B705F25-CC97-4DCC-BFD0-0C6654586271Q26830683-6BD3D823-7A5B-4B95-81D5-10B5FC210DEDQ26852714-0DD73218-A763-43F9-8D71-976FB667DAF9Q26853285-7BF44DBC-9602-4751-9A96-1CE922E8833AQ27008164-252E5680-783D-49BD-9C2D-E72815A3EEE1Q28070016-B98FA6BC-B0F7-4DDB-8C9A-55FA9A22E55EQ28081884-DC213A90-1B42-4B7D-9485-E4EC21B96F5AQ28268467-F53EAFC5-BD3E-48F0-8F62-A669B8A43F84Q33268075-EFBA1F9E-57A8-446F-B8B8-F6FED3E1C468Q33432064-AC593142-482E-4210-BA3B-DEB3A72742B9Q33451900-F7C822FF-BA92-48CE-BA5C-186E31C2F7FDQ33724343-CF1B8DE9-BDF3-42D8-B623-E6E50DD403B6Q33735218-7C86E292-3D71-4D26-8DDD-2A512E31B216Q33735229-10FAF599-F48E-4B60-BC8E-E89FEAFE030DQ33764582-C3E13C48-BC8E-4305-944D-DDA5FCEC05A9Q33795126-14096135-73B1-45CA-A18D-9AA3207A2DD5Q33855518-F034AEDF-E763-408F-BFD7-DD06ACC3E981Q33915249-4314FB63-AA1C-438C-8CFA-EDDD71E7B0E2Q33958853-B515029E-0A1B-4AEA-BE57-D0024637B5C8Q34552619-196EF63A-FA01-41CE-9137-F401B9A9E45EQ34603139-C328B519-0396-4CCD-836B-A4A897449A97Q34626602-FFF7DF92-E6A4-40B6-80D2-A8A34E58A9C0Q34673928-680DA19D-16CB-4E00-B85E-0363AE9AC93EQ34790812-C6780FA2-8939-4C40-9BF7-AABAB9AE1B19Q34792198-CC6957C5-5F49-45B2-946E-B5B50104E8B6Q35083388-A8496243-0092-4DE5-98E5-CA90CF24C691Q35178813-41C6234B-21F9-4FFA-A1DB-0A423319E6CAQ35536026-D7324DF8-E440-4467-939E-2A3DEED09B57Q35569347-EED26442-48B3-4A79-9F28-AD14F75B8A21Q35595593-06303487-EF62-4933-A144-038E4A2F115AQ35596886-A65788E9-2CA3-4053-8214-F25854E46C70Q35809437-37B9F82C-2FE8-42A3-A9FC-BFA19BEA3607Q35878694-7FFA308D-64F1-47FE-9834-F584967E2499Q36036768-B9F74E73-6FD8-48F1-B6AC-986F9744A8C7Q36174384-97BDD89D-C0E8-48FA-9960-E8FDF2FFA68EQ36230130-6FD376B2-EAD2-4381-BC9D-E01331FA7303Q36407290-8BF872B7-F3AF-4ADC-B993-68AFD6E07AE0Q36419333-5816A6C8-66EB-44E1-BF91-F56ABB0DCA23Q36428700-62D065DA-F578-4F94-96AE-CF00B3954A92Q36478089-A5560685-30FB-454B-9D83-9113857E3DAC
P2860
Increased platelet depleted plasma 5-hydroxytryptamine concentration following meal ingestion in symptomatic female subjects with diarrhoea predominant irritable bowel syndrome
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Increased platelet depleted pl ...... inant irritable bowel syndrome
@ast
Increased platelet depleted pl ...... inant irritable bowel syndrome
@en
type
label
Increased platelet depleted pl ...... inant irritable bowel syndrome
@ast
Increased platelet depleted pl ...... inant irritable bowel syndrome
@en
prefLabel
Increased platelet depleted pl ...... inant irritable bowel syndrome
@ast
Increased platelet depleted pl ...... inant irritable bowel syndrome
@en
P2093
P2860
P356
P1433
P1476
Increased platelet depleted pl ...... inant irritable bowel syndrome
@en
P2093
L A Houghton
M J Rimmer
P J Whorwell
R P Whitaker
W Atkinson
P2860
P304
P356
10.1136/GUT.52.5.663
P407
P577
2003-05-01T00:00:00Z